Jonathan Kay to Imatinib Mesylate
This is a "connection" page, showing publications Jonathan Kay has written about Imatinib Mesylate.
Connection Strength
0.102
-
Kay J, High WA. Imatinib mesylate treatment of nephrogenic systemic fibrosis. Arthritis Rheum. 2008 Aug; 58(8):2543-8.
Score: 0.078
-
Lin HW, Roberts DS, Kay J, Stankovic KM. Sensorineural hearing loss following imatinib (Gleevec) administration. Otolaryngol Head Neck Surg. 2012 Feb; 146(2):335-7.
Score: 0.024